Beacon Therapeutics
PrivateLast Round
Series C
Jan 8, 2026
Est. Valuation
$618.75M
Total Funding Raised
$365M
Company Overview
Beacon Therapeutics is a biotechnology company focused on developing innovative gene therapies to treat patients with rare lung and eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beacon Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Beacon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 8, 2026 | ||||
| Series B | Jul 3, 2024 | ||||
| Series A | Jun 12, 2023 |
Beacon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Retinal Degeneration Fund | Series C |
| Forbion Capital Partners | Series B |
| TCG Crossover | Series B |
| Forbion | Series C |
| Syncona | Series B, Series C, Series A |
| Oxford Science Enterprises | Series A, Series B, Series C |
| Life Sciences at Goldman Sachs Alternatives | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
$75M round raised at $618.75M post-money valuation.
- Jan 8, 2026
Colin Walsh, Managing Director at Goldman Sachs Alternatives, joins the board.
Beacon Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beacon Therapeutics's valuation, stock price, and market status.
